After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, VERU falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Veru Inc is $76.83M. A total of 0.78 million shares were traded on the day, compared to an average of 3.48M shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, VERU has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Rankowitz Michael L bought 95,279 shares of VERU for 0.55 per share on Feb 18 ’25. After the transaction, the Director now owns 195,279 company shares. In a previous transaction on Feb 19 ’25, Rankowitz Michael L bought 54,721 shares at 0.58 per share. VERU shares that Director owns now total 250,000.
Among the insiders who bought shares, FISCH HARRY acquired of 4,000 shares on May 24 ’24 at a per-share price of $1.25. This resulted in the Chief Corporate Officer holding 774,736 shares of VERU after the transaction. In another insider transaction, BARNETTE K GARY bought 5,000 shares at $1.34 per share on May 24 ’24. Company shares held by the Chief Scientific Officer now total 5,000.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for VERU in the last 3 months, the mean price target is $3.20 with high estimates of $5.00 and low estimates of $1.00. In terms of 52-week highs and lows, VERU has a high of $1.92 and a low of $0.47.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. VERU’s latest balance sheet shows that the firm has $122.36M in Cash & Short Term Investments as of fiscal 2021. There were $13.74M in debt and $15.77M in liabilities at the time. Its Book Value Per Share was $0.18, while its Total Shareholder’s Equity was $152.29M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VERU is Buy with a score of 4.40.
